在臨床一線工作十余年，積累了豐富的臨床經(jīng)驗，熟練掌握常見傳染病、多發(fā)病的診治技術(shù)。認真負責對待每一位病人，作風踏實，思路縝密。作為主要成員之一，參與多項重大課題（包括傳染病防治重大科技專項、國家科技攻關(guān)、國家自然科學基金重點項目、863計劃等）；參編《臨床感染病學》、《人工肝臟》等書籍。主要發(fā)表的文章如下：
1. Liu XL, Li LJ, Chen Z. Isolation and primary culture of rat hepatocytes. Hepatobiliary Pancreat Dis Int, 2002, 1:77-79.
2. 劉小麗，李蘭娟. SELDI-TOF MS技術(shù)及其在傳染性疾病研究中的應(yīng)用. 國外醫(yī)學∙流行病學傳染病學分冊. 2005,32:149-152.
3. Li LJ, Liu XL, Xu XW, Sheng GP, Chen Y, Chen YM, Huang JR, Yang Q. Comparison of plasma exchange with different membrane pore sizes in the treatment of severe viral hepatitis. Ther Apher, 2005, 9:396-401.
4. Du WB, Li LJ, Huang JR, Yang Q, Liu XL, Li J, Chen YM, Cao HC, Xu W, Fu SZ, Chen YG. Effects of artificial liver support system on patients with acute or chronic liver failure. Transplant Proc 2005; 37(10):4359-4364
5. Yang J, Zhao X, Liu X, Wang C, Gao P, Wang J, Li L, Gu J, Yang S, Xu G. High performance liquid chromatography-mass spectrometry for metabonomics: potential biomarkers for acute deterioration of liver function in chronic hepatitis B. J Proteome Res, 2006, 5:554-561.
6. Li LJ, Zhang YM, Liu XL. ALSS in China. Ther Apher 2006, 10: 160–167.
7. Liu X, Li L, Zhang G, Sheng G, Xu W. An approach to characterizing serum low molecular weight proteins in liver injury with SELDI-TOF MS and factor analysis. Clin Biochem, 2007, 40: 1266-1271.
8. 劉小麗, 李蘭娟, 盛國平, 徐威, 徐亮. 重型肝炎預(yù)后相關(guān)的低分子量蛋白質(zhì)譜研究. 中華傳染病雜志2007，25： 327-331.
9. Yu K, Sheng G, Sheng J, Chen Y, Xu W, Liu X, Cao H, Qu H, Cheng Y, Li L. A metabonomic investigation on the biochemical perturbation in liver failure patients caused by hepatitis B virus. J Proteome Res. 2007, 6:2413-2419
10. 劉小麗, 盛國平, 徐威, 李蘭娟. 慢性重型肝炎患者血清中的低分子量蛋白質(zhì)研究. 中國病理生理雜志. 2008, 24:1794-1798.
11. Zou Y, Ni Y, Liu X(通訊作者), Chen X. Misdiagnosis of Behçet's disease with unknown protracted fever and chill after surgical excision of cardiac tumor. Rheumatol Int. 2012, 32:2177-2179.
